| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.1996.TB34448.X |
| P698 | PubMed publication ID | 8624116 |
| P2093 | author name string | Martin E | |
| Knapp S | |||
| Hoyer S | |||
| Henneberg N | |||
| Lannert H | |||
| P2860 | cites work | Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus | Q48241240 |
| Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex | Q48687171 | ||
| Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. | Q53312877 | ||
| Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo | Q33898881 | ||
| ATP receptor-mediated synaptic currents in the central nervous system | Q34250363 | ||
| The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance | Q36459941 | ||
| Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects | Q37295536 | ||
| ATP and brain function | Q38597443 | ||
| Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat. | Q48090329 | ||
| Short-term mental activation accelerates the age-related decline of high-energy phosphates in rat cerebral cortex | Q48090861 | ||
| Age as risk factor for sporadic dementia of the Alzheimer type? | Q48120495 | ||
| Insulin receptor substrate-1 (IRS-1) expression in rat brain | Q48153642 | ||
| Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia | Q48164876 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | desensitization | Q2700499 |
| P304 | page(s) | 374-379 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor | |
| P478 | volume | 777 |
| Q33546151 | Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches |
| Q34646469 | Ammonia and Alzheimer's disease |
| Q35695006 | Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases |
| Q38075505 | Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. |
| Q37930196 | Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes |
| Q34303597 | Cognitive effects of insulin in the central nervous system |
| Q41995767 | Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease |
| Q34231361 | Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism |
| Q48378068 | Gender- and region-specific expression of insulin receptor protein in mouse brain: effect of mild inhibition of oxidative phosphorylation |
| Q90718287 | GluT4: A central player in hippocampal memory and brain insulin resistance |
| Q91760817 | Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients |
| Q38041488 | Insulin in the brain: sources, localization and functions. |
| Q35681597 | Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis |
| Q38980167 | Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links. |
| Q34464773 | Ketogenic diet, amino acid metabolism, and seizure control |
| Q33786519 | Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet |
| Q89273094 | Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a 13C NMR metabolomic study |
| Q42557527 | Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells |
| Q50978223 | Neuroprotective efficacy of Nardostachys jatamansi and crocetin in conjunction with selenium in cognitive impairment. |
| Q38668948 | Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases |
| Q37857377 | Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis |
| Q48596436 | Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze. |
| Q60959857 | The Effect of Intrahippocampal Insulin Infusion on Spatial Cognitive Function and Markers of Neuroinflammation in Diet-induced Obesity |
| Q44401025 | The glucose paradox of cerebral ischemia: evidence for corticosterone involvement |
| Q36231289 | The insulin regulatory network in adult hippocampus and pancreatic endocrine system |
Search more.